ISRCTN58244066已完成不适用

Asthma Reduction with Inhaled corticoSteroids in Children with a high risk for the development of asthma (At RISC)

Care and Public Health Research Institute (CAPHRI), University Maastricht (Netherlands)0 个研究点目标入组 97 人开始时间: 2006年1月27日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Male and female patients aged 1-4.5 years with a familial predisposition for asthma in the first degree, who have experienced at least 2 separate periods with wheeze lasting at least 2 days each documented by their general practitioner
•2. For each patient who enters the study a written informed consent by the parent or guardian of the patient should be obtained

•1. Patients who have been treated with pulmonary anti-inflammatory inhaled drugs for more than 2 weeks or anti-inflammatory oral drugs for more than 1 week preceding the study
•2. Patients who have been hospitalised for asthma in the 2 weeks prior to the study
•3. Patients who have serious respiratory morbidity (e.g. broncho-pulmonary dysplasia, cystic fibrosis, tuberculosis)
•4. Patients, who have laboratory or clinical evidence of serious uncontrolled systemic disease (as judged by the investigator)
•5. Patients with anatomical abnormalities of the upper airways or lungs
•6. Patients currently participating in another drug intervention study
•7. When the general practitioner considers it detrimental to the patient to participate in the study

发起方

Care and Public Health Research Institute (CAPHRI), University Maastricht (Netherlands)